Published on December 17, 2009 at 12:49 AM
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving
science, today announced it has been selected as the National
Children’s Study (NCS) biological and environmental sample repository
partner. The study examines the effects of environmental influences
on the health and development of 100,000 children across the United
States, following them from before birth until age 21. The contract was
awarded to the company’s Fisher BioServices business by the National
Institutes of Health in conjunction with a consortium that includes the
Centers for Disease Control and Prevention and the Environmental
Protection Agency.
“This is a monumental study that stands to transform our knowledge of
human development, provide insight into diseases and push medical
research forward,” said Marc N. Casper, president and chief executive
officer of Thermo Fisher Scientific. “We’re honored to play such an
important role in this work. The project demands the careful handling
and storing of countless samples over many years, and Fisher
BioServices’ track record as the leader in biorepository services made
this an ideal alliance.”
The company will establish a biorepository to handle the organization,
storing and disbursement of patient specimens and environmental samples
for the duration of the study. Expert personnel will monitor specimen
integrity over time and the Fisher BioServices IN-TRAK®
inventory management system will interface with the NCS information
management system to give researchers on-line access to stored samples.
Fisher BioServices is a professional contract services business with
more than 23 years of experience in biological repository services and
cold chain logistics, managing high value biological specimens,
cell-based therapeutics, vaccines and tissues. The business manages more
than 170,000,000 samples globally, serving more than 30 governments and
300 commercial customers.
http://www.thermofisher.com/